Fate Therapeutics Cash Flow Statement (2012-2026) | FATE

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-46.43M-54.33M-69.08M-74.05M-82.35M-84.60M-61.54M-24.90M-58.18M-46.58M-43.66M-46.92M-40.26M-47.94M-57.87M-37.94M-34.05M-32.16M-32.50M-31.13M
Share-based Compensation (Quarter)
13.25M13.54M14.59M19.33M20.54M19.47M19.39M10.98M12.90M10.10M9.47M10.98M9.63M11.77M9.12M7.38M7.15M4.86M5.53M3.93M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)
0.10M7.05M0.16M-0.06M-0.94M-0.04M
Non-cash Items (Quarter)
Cash from Operations (Quarter)
-32.11M-33.38M-70.29M-64.61M-53.16M-55.05M-75.39M-28.86M-28.49M-38.27M-36.64M-33.35M-32.31M-29.42M-27.80M-33.81M-24.59M-24.37M-23.31M-30.82M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-1.49M-1.37M-1.07M-0.87M-0.53M0.41M1.25M2.29M2.94M3.26M2.91M2.63M2.72M2.20M1.53M1.07M0.85M0.81M0.88M0.77M
Amortization of Deferred Charges (Quarter)
0.98M1.11M1.29M1.09M-0.33M0.78M1.13M7.20M
Depreciation & Amortization (CF) (Quarter)
1.17M1.52M2.21M2.76M2.96M3.19M4.88M4.19M4.47M4.74M4.88M4.82M4.72M4.61M4.81M3.33M3.28M3.23M3.06M2.92M
Change in Working Capital
Change in Receivables (Quarter)
3.36M-2.99M1.36M5.17M-0.72M-2.90M28.26M-24.98M-10.67M-1.30M0.29M-0.97M0.19M2.48M-0.59M-1.13M-1.01M-0.71M0.23M-0.21M
Change in Accured Expenses (Quarter)
2.61M6.74M-10.38M-3.49M4.08M10.28M3.39M-20.39M-4.37M-2.28M-1.89M-4.51M0.32M1.87M0.66M-9.83M0.48M-0.55M0.86M-5.77M
Investing Activities
Capital Expenditures (Quarter)
13.62M-13.98M0.75M3.38M16.84M-18.23M-0.93M3.21M2.20M0.56M-5.97M0.01M0.09M-0.09M0.12M0.66M1.90M2.20M-4.76M0.01M
Sales of Property, Plant and Equipment (Quarter)
0.00M0.24M
Change in Acquisitions & Divestments (Quarter)
111.58M258.16M263.09M135.22M114.36M190.63M166.89M127.00M127.63M127.50M95.50M103.73M75.34M90.70M60.92M92.49M71.64M81.45M66.32M52.55M
Cash from Investing Activities (Quarter)
-1.37M77.96M71.28M-7.03M40.29M80.38M53.11M9.34M33.17M24.80M45.35M17.31M-53.37M25.46M22.82M42.67M19.59M21.27M27.63M23.59M
Financing Activities
Other financing activities (Quarter)
0.06M0.56M-0.56M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Long-Term Debt Repayments (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
3.72M11.36M-20.68M2.80M3.41M1.49M1.52M0.27M-0.27M20.00M54.53M-54.53M
Shares Repurchased (Quarter)
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)
3.72M7.94M3.42M2.80M3.41M1.49M1.52M0.21M0.06M-0.18M95.49M1.27M3.13M1.32M2.48M1.69M
Change in Cash (Quarter)
-29.76M52.53M4.40M-68.84M-9.47M26.82M-20.76M-19.31M4.73M-13.47M8.54M79.45M-84.41M-3.96M-1.85M8.86M-3.67M-0.63M6.01M-7.24M
Free Cash Flow (Quarter)
-45.73M-19.40M-71.04M-67.99M-70.00M-36.82M-74.46M-32.07M-30.69M-38.84M-30.66M-33.36M-32.39M-29.33M-27.92M-34.46M-26.49M-26.58M-18.55M-30.84M
Net Cash Flow (Quarter)
-29.76M52.53M4.40M-68.84M-9.47M26.82M-20.76M-19.31M4.73M-13.47M8.54M79.45M-84.41M-3.96M-1.85M8.86M-3.67M-0.63M6.01M-7.24M